Retina

193-208 of 340

How Treatments for DR/DME are Modernizing Medical Retina
How Treatments for DR/DME are Modernizing Medical Retina
CME/CE
How Treatments for DR/DME are Modernizing Medical Retina
Sophie J. Bakri, MD; Christina Y. Weng, MD, MBA
1.00 credit
- Sophie J. Bakri, MD
- Christina Y. Weng, MD, MBA
- David A. Eichenbaum, MD, FAAO
- Glenn Yiu, MD, PhD
1.00 credit
Challenges With Postoperative Posterior Segment Inflammation
Challenges With Postoperative Posterior Segment Inflammation
CME/CE Broadcast Replay
Challenges With Postoperative Posterior Segment Inflammation
David A. Eichenbaum, MD, FAAO; Daniel F. Kiernan, MD, FACS
1.00 credit
- David A. Eichenbaum, MD, FAAO
- Daniel F. Kiernan, MD, FACS
1.00 credit
End-of-study Results for the Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-related Macular Degeneration
End-of-study Results for the Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-related Macular Degeneration
CME/CE
End-of-study Results for the Ladder Phase 2 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-related Macular Degeneration
Philip Storey, MD, MPH
0.25 credits
- Philip Storey, MD, MPH
0.25 credits
Development of Macular Atrophy After Pars Plana Vitrectomy for Myopic Traction Maculopathy and Macular Hole Retinal Detachment in Pathologic Myopia
Development of Macular Atrophy After Pars Plana Vitrectomy for Myopic Traction Maculopathy and Macular Hole Retinal Detachment in Pathologic Myopia
CME/CE
Development of Macular Atrophy After Pars Plana Vitrectomy for Myopic Traction Maculopathy and Macular Hole Retinal Detachment in Pathologic Myopia
Musa Abdelaziz, MD
0.25 credits
- Musa Abdelaziz, MD
0.25 credits
Outcomes of Infectious Endophthalmitis in Patients With Systemic Antibiotic Allergies to Penicillins, Cephalosporins or Vancomycin
Outcomes of Infectious Endophthalmitis in Patients With Systemic Antibiotic Allergies to Penicillins, Cephalosporins or Vancomycin
CME/CE
Outcomes of Infectious Endophthalmitis in Patients With Systemic Antibiotic Allergies to Penicillins, Cephalosporins or Vancomycin
Rehan M. Hussain, MD
0.25 credits
- Rehan M. Hussain, MD
0.25 credits
Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment
Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment
CME/CE
Laser Treatment After Minimized Eye Movement for Repair of Retinal Detachment
Avni P. Finn, MD, MBA
0.25 credits
- Avni P. Finn, MD, MBA
0.25 credits
Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience
Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience
CME/CE
Telehealth-based Eye Care During the COVID-19 Pandemic: Utilization, Safety, and the Patient Experience
Jaya B. Kumar, MD
0.25 credits
- Jaya B. Kumar, MD
0.25 credits
Long-term Anti-vascular Endothelial Growth Factor Treatment for Neovascular Age-related Macular Degeneration: the LATAR Study
Long-term Anti-vascular Endothelial Growth Factor Treatment for Neovascular Age-related Macular Degeneration: the LATAR Study
CME/CE
Long-term Anti-vascular Endothelial Growth Factor Treatment for Neovascular Age-related Macular Degeneration: the LATAR Study
Vlad Matei, MD
0.50 credits
- Vlad Matei, MD
0.50 credits
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
CME/CE Broadcast Replay
Diabetic Eye Disease Pipeline Therapies Part 1: Faricimab, KSI-301, and OPT-302
Christina Y. Weng, MD, MBA; David A. Eichenbaum, MD, FAAO
0.50 credits
- Christina Y. Weng, MD, MBA
- David A. Eichenbaum, MD, FAAO
0.50 credits
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
COPE ACCREDITED CE OFFERED
Preparing for the Future: Updates in Retinal Diseases and Novel Therapies
Ehsan Rahimy, MD
1.00 credit
- Ehsan Rahimy, MD
1.00 credit
Combating Diabetic Eye Disease and Patients at Risk for Loss to Follow-Up
Combating Diabetic Eye Disease and Patients at Risk for Loss to Follow-Up
CME/CE Broadcast Replay
Combating Diabetic Eye Disease and Patients at Risk for Loss to Follow-Up
Allen C. Ho, MD; Katherine Talcott, MD
0.75 credits
- Allen C. Ho, MD
- Katherine Talcott, MD
0.75 credits
Clinical Outcomes and Treatment Course of Eyes With Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis
Clinical Outcomes and Treatment Course of Eyes With Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis
CME/CE
Clinical Outcomes and Treatment Course of Eyes With Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis
Judy J. Chen, MD
0.25 credits
- Judy J. Chen, MD
0.25 credits
Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery
Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery
CME/CE
Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery
Edward H. Wood, MD
0.25 credits
- Edward H. Wood, MD
0.25 credits
Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction With and Without Macular Hole: DRCR Retina Network Protocols AG and AH
Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction With and Without Macular Hole: DRCR Retina Network Protocols AG and AH
CME/CE
Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction With and Without Macular Hole: DRCR Retina Network Protocols AG and AH
Joshua Levinson, MD
0.25 credits
- Joshua Levinson, MD
0.25 credits
Customizing Treatment Plans for the Diabetic Patient - On-demand
Customizing Treatment Plans for the Diabetic Patient - On-demand
CME/CE Broadcast Replay
Customizing Treatment Plans for the Diabetic Patient - On-demand
John W. Kitchens, MD; Allen C. Ho, MD
1.00 credit
- John W. Kitchens, MD
- Allen C. Ho, MD
1.00 credit
Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents
Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents
CME/CE
Risk factors for severe bleeding complications in vitreoretinal surgery and the role of antiplatelet or anticoagulant agents
Wenlan (Wendy) Zhang, MD
0.25 credits
- Wenlan (Wendy) Zhang, MD
0.25 credits

13/11